Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review.

Candelas G, Martinez-Lopez JA, Rosario MP, Carmona L, Loza E.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):954-61. Epub 2012 Dec 17. Review.

PMID:
23137489
2.

Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women.

Haghighi A, Samimagham H, Gohardehi G.

Iran J Kidney Dis. 2013 May 21;7(3):210-3.

3.

Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women.

Domrongkitchaiporn S, Ongphiphadhanakul B, Stitchantrakul W, Piaseu N, Chansirikam S, Puavilai G, Rajatanavin R.

Osteoporos Int. 2000;11(6):486-92.

PMID:
10982163
4.

Calcium supplementation and incident kidney stone risk: a systematic review.

Heaney RP.

J Am Coll Nutr. 2008 Oct;27(5):519-27. Review.

PMID:
18845701
5.

Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.

Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.

J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.

PMID:
19152919
6.
7.

Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Williams CP, Child DF, Hudson PR, Davies GK, Davies MG, John R, Anandaram PS, De Bolla AR.

J Clin Pathol. 2001 Jan;54(1):54-62.

8.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

9.

Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen.

Domrongkitchaiporn S, Ongphiphadhanakul B, Stitchantrakul W, Chansirikarn S, Puavilai G, Rajatanavin R.

Maturitas. 2002 Feb 26;41(2):149-56.

PMID:
11836046
10.

Medical therapy to facilitate the passage of stones: what is the evidence?

Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U.

Eur Urol. 2009 Sep;56(3):455-71. doi: 10.1016/j.eururo.2009.06.012. Epub 2009 Jun 21. Review.

PMID:
19560860
11.

Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.

Sakhaee K, Poindexter JR, Griffith CS, Pak CY.

J Urol. 2004 Sep;172(3):958-61.

PMID:
15311008
12.

Nephrolithiasis from calcium supplementation.

Pak CY, Sakhaee K, Hwang TI, Preminger GM, Harvey JA.

J Urol. 1987 Jun;137(6):1212-3. No abstract available.

PMID:
3586158
13.

[Assessment of oxalate concentration in serum and urine of children with renal stones].

Jadeszko I, Porowski T, Zoch-Zwierz WM, Wasilewska AM, Hackiewicz L.

Wiad Lek. 2005;58 Suppl 1:20-4. Polish.

PMID:
16060079
14.

[Protective use of calcium in case of osteoporosis versus calcium oxalate stones].

Hamwi I, Stichtenoth DO, Picksak G.

Med Monatsschr Pharm. 2008 Nov;31(11):434-5. Review. German.

PMID:
19058382
15.

Does calcium supplementation increase cardiovascular risk?

Reid IR, Bolland MJ, Grey A.

Clin Endocrinol (Oxf). 2010 Dec;73(6):689-95. doi: 10.1111/j.1365-2265.2010.03792.x. Review.

PMID:
20184602
16.

Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.

Pentti K, Tuppurainen MT, Honkanen R, Sandini L, Kröger H, Alhava E, Saarikoski S.

Maturitas. 2009 May 20;63(1):73-8. doi: 10.1016/j.maturitas.2009.03.006. Epub 2009 Apr 24.

PMID:
19394167
17.

Postmenopausal osteoporosis treatment and risk of urinary calculus development.

Ganji MR.

Iran J Kidney Dis. 2013 May;7(3):171-4. No abstract available.

18.
19.

Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.

Nurmi-Lüthje I, Lüthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, Karjalainen K.

Drugs Aging. 2009;26(5):409-21. doi: 10.2165/00002512-200926050-00005.

PMID:
19552493
Items per page

Supplemental Content

Write to the Help Desk